Testing Experimental Treatment for Advanced Solid Tumors

A Study of LY3435151 in Participants With Solid Tumors

The reason for this study is to see if the study drug LY3435151 is safe in participants with advanced solid tumors.

Pharmaceutical medication involved
Recruiting patients only

Drug - LY3435151

Administered IV

Drug - Pembrolizumab

Administered IV

A Phase 1a/1b Study of LY3435151 Administered to Patients With Advanced Solid Tumors